{"entity":{"type":"insider","cik":"0001956241","url":"/insider/0001956241","json_url":"/insider/0001956241.json","name":"Xynos Konstantinos","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":9,"first":"2023-05-18","last":"2026-08-12","span_basis":"filed_date"},"name_variants":[{"name":"Xynos Konstantinos","source":"filing","n_filings":9,"first_seen":"2023-05-18","last_seen":"2026-08-12"}],"transactions":[{"id":9224052,"accession":"0001104659-26-095006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-095006","line_url":"/filing/0001104659-26-095006#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001956241","owner_name":"Xynos Konstantinos","owner_display_name":"Xynos Konstantinos","owner_url":"/insider/0001956241","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11447.0,"shares_display":"11,447","price_per_share":12.97,"price_display":"12.97","price_state":"stated","total_value":148467.59,"total_display":"148,467.59","total_whole":"148,468","shares_owned_after":224215.0,"shares_owned_after_display":"224,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-12","scope":"insider"},{"id":6151137,"accession":"0001104659-26-064526","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-064526","line_url":"/filing/0001104659-26-064526#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001956241","owner_name":"Xynos Konstantinos","owner_display_name":"Xynos Konstantinos","owner_url":"/insider/0001956241","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14023.0,"shares_display":"14,023","price_per_share":5.08,"price_display":"5.08","price_state":"stated","total_value":71236.84,"total_display":"71,236.84","total_whole":"71,237","shares_owned_after":235662.0,"shares_owned_after_display":"235,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-18","filed_date":"2026-05-20","scope":"insider"},{"id":4630382,"accession":"0001104659-25-114122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-114122","line_url":"/filing/0001104659-25-114122#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001956241","owner_name":"Xynos Konstantinos","owner_display_name":"Xynos Konstantinos","owner_url":"/insider/0001956241","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7248.0,"shares_display":"7,248","price_per_share":9.1,"price_display":"9.10","price_state":"stated","total_value":65956.8,"total_display":"65,956.80","total_whole":"65,957","shares_owned_after":139685.0,"shares_owned_after_display":"139,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-19","scope":"insider"},{"id":4327016,"accession":"0001104659-25-052145","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-052145","line_url":"/filing/0001104659-25-052145#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001956241","owner_name":"Xynos Konstantinos","owner_display_name":"Xynos Konstantinos","owner_url":"/insider/0001956241","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7952.0,"shares_display":"7,952","price_per_share":8.06,"price_display":"8.06","price_state":"stated","total_value":64093.12,"total_display":"64,093.12","total_whole":"64,093","shares_owned_after":146933.0,"shares_owned_after_display":"146,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-20","filed_date":"2025-05-22","scope":"insider"},{"id":2035560,"accession":"0001104659-24-121188","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-121188","line_url":"/filing/0001104659-24-121188#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001956241","owner_name":"Xynos Konstantinos","owner_display_name":"Xynos Konstantinos","owner_url":"/insider/0001956241","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7246.0,"shares_display":"7,246","price_per_share":10.78,"price_display":"10.78","price_state":"stated","total_value":78111.88,"total_display":"78,111.88","total_whole":"78,112","shares_owned_after":109885.0,"shares_owned_after_display":"109,885","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-20","scope":"insider"},{"id":2434857,"accession":"0001104659-24-070108","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-070108","line_url":"/filing/0001104659-24-070108#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001956241","owner_name":"Xynos Konstantinos","owner_display_name":"Xynos Konstantinos","owner_url":"/insider/0001956241","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15881.0,"shares_display":"15,881","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":119107.5,"total_display":"119,107.50","total_whole":"119,108","shares_owned_after":117131.0,"shares_owned_after_display":"117,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-07","filed_date":"2024-06-10","scope":"insider"},{"id":2085811,"accession":"0001104659-24-063558","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-063558","line_url":"/filing/0001104659-24-063558#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001956241","owner_name":"Xynos Konstantinos","owner_display_name":"Xynos Konstantinos","owner_url":"/insider/0001956241","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6367.0,"shares_display":"6,367","price_per_share":6.47,"price_display":"6.47","price_state":"stated","total_value":41194.49,"total_display":"41,194.49","total_whole":"41,194","shares_owned_after":133012.0,"shares_owned_after_display":"133,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-20","scope":"insider"},{"id":8319731,"accession":"0001104659-23-119646","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-119646","line_url":"/filing/0001104659-23-119646#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001956241","owner_name":"Xynos Konstantinos","owner_display_name":"Xynos Konstantinos","owner_url":"/insider/0001956241","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7313.0,"shares_display":"7,313","price_per_share":10.92,"price_display":"10.92","price_state":"stated","total_value":79857.96,"total_display":"79,857.96","total_whole":"79,858","shares_owned_after":112714.0,"shares_owned_after_display":"112,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-17","scope":"insider"},{"id":8429654,"accession":"0001104659-23-062373","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-062373","line_url":"/filing/0001104659-23-062373#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001956241","owner_name":"Xynos Konstantinos","owner_display_name":"Xynos Konstantinos","owner_url":"/insider/0001956241","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":771.0,"shares_display":"771","price_per_share":18.05,"price_display":"18.05","price_state":"stated","total_value":13916.55,"total_display":"13,916.55","total_whole":"13,917","shares_owned_after":120027.0,"shares_owned_after_display":"120,027","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001737953","name":"Replimune Group, Inc.","url":"/issuer/0001737953","role":"Officer (Chief Medical Officer)","n_filings":9,"first_seen":"2023-05-18","last_seen":"2026-08-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001956241","retrieved_at":"2026-08-24T19:30:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}